Provided by Tiger Trade Technology Pte. Ltd.

LB Pharmaceuticals

30.36
-1.0550-3.36%
Volume:16.58K
Turnover:508.13K
Market Cap:868.33M
PE:-11.70
High:30.95
Open:30.84
Low:30.10
Close:31.41
52wk High:33.47
52wk Low:13.36
Shares:28.61M
Float Shares:19.00M
Volume Ratio:0.55
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5941
EPS(LYR):-3.1329
ROE:-20.02%
ROA:-13.68%
PB:2.29
PE(LYR):-9.69

Loading ...

May 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2026

Major Issues Report

Form 8-K - Current report
Apr 11, 2026

Correspondence

Form CORRESP - Correspondence
Apr 06, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 26, 2026

Major Issues Report

Form 8-K - Current report
Mar 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2026

Major Issues Report

Form 8-K - Current report
Mar 10, 2026

Major Issues Report

Form 8-K - Current report
Feb 05, 2026

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 12, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Sep 12, 2025

Major Issues Report

Form 8-K - Current report
Sep 11, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 09, 2025

Correspondence

Form CORRESP - Correspondence
Sep 09, 2025

Correspondence

Form CORRESP - Correspondence
Sep 08, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]